Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system | CMAC

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system

Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):34-40

​ Skryabina A.A., Nikiforov V.V., Shakhmardanov M.Z., Zastrozhin M.S., Skryabin V.Yu., Sychev D.A.
10.36488/cmac.2023.1.34-40
antibiotics pharmacovigilance spontaneous reports macrolides adverse drug reactions
Section
Antimicrobials
Type
Original Article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):34-40

Objective.

To perform pharmacoepidemiological analysis of spontaneous reports of adverse drug reactions (ADRs) occurred during macrolide group antibiotics prescription and registered in the “Pharmacovigilance 2.0” subsystem of the Federal Service for Surveillance in Healthcare.

Materials and Methods.

A retrospective pharmacoepidemiological analysis of spontaneous reports of ADRs arising from the use of all macrolide and azalide antibiotics registered in Russia and registered in the electronic database of the “Pharmacovigilance 2.0” subsystem of the Federal Service for Surveillance in Healthcare for the period from 01.04.2019 to 30.11.2022 was performed.

Results.

Analysis of the number of spontaneous reports of ADRs, their structure, outcomes and severity criteria was performed. The most clinically significant ADRs were identified, the occurrence of which was reported to pharmacovigilance bodies. The results of a retrospective pharmacoepidemiological analysis showed that the development of complications of pharmacotherapy in most cases was associated with the use of azithromycin and clarithromycin. The main clinical manifestations of adverse drug reactions were skin and subcutaneous tissue disorders, gastrointestinal disorders, as well as general disorders and injection site reactions.

Conclusions.

It was found that the reported events generally corresponded to the general spectrum of ADRs typical for individual representatives of macrolide and azalide antibiotics.

Anna A. Skryabina

Pirogov Russian National Research Medical University, Moscow, Russia

Nikiforov V.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Shakhmardanov M.Z.

Pirogov Russian National Research Medical University, Moscow, Russia

Zastrozhin M.S.

Russian Medical Academy of Continuous Professional Education, Moscow, Russia

Skryabin V.Yu.

Russian Medical Academy of Continuous Professional Education, Moscow, Russia
Moscow Research and Practical Centre on Addictions, Moscow, Russia

Dmitriy A. Sychev

Russian Medical Academy of Continuous Professional Education, Moscow, Russia

  • 1. Murashko M.A., Parkhomenko D.V., Asetskaya I.L., Kosenko V.V., Polivanov V.A., Glagolev S.V. Current issues of drug safety monitoring in the Russian Federation. Obstetrics and gynecology. 2015;2:72-80. Russian.
  • 2. Zyryanov S.K., Zatolochina K.E., Kazakov A.S. Current issues of patient safety: the role of pharmacovigilance. Obshhestvennoe zdorov'e. 2022;2(3):25-34. Russian. DOI: 10.21045/2782-1676-20212-3-25-34
  • 3. Decision of the Council of the Eurasian Economic Commission of 03.11.2016 № 87 (revised on 19.05.2022) “On approval of the rules of Good Pharmacovigilance Practice of the Eurasian Economic Union”. Available at: https://docs.cntd.ru/document/456026106?ysclid=lcjemp8ukj272943824. Accessed March 29, 2023. Russian.
  • 4. Perova N.N., Ryabchunova L.V., Golovina V.N. Development of pharmacovigilance services in medical institutions. Mnogoprofil'nyj stacionar. 2019;6(1):37-43. Russian.
  • 5. Sychev D.A. Polypragmasy in clinical practice: problems and solutions. Educational and methodical manual. Russian Medical Academy of Postgraduate Education. Moscow, 2016. Russian.
  • 6. Federal Law No. 61-FZ “On circulation of medicines” dated April 12, 2010. Available at: https://docs.cntd.ru/document/902209774. Accessed March 29, 2023. Russian.
  • 7. Order of Roszdravnadzor No. 1071 of 15.02.2017 “On approval of the procedure for pharmacovigilance”. Available at: https://docs.cntd.ru/document/420394411. Accessed March 29, 2023. Russian.
  • 8. Kostyleva M.N., Belousov Yu.B., Gratsianskaya A.N., Postnikov S.S. Safety assessment of drug therapy in clinical practice. Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2014;7(1):2631. Russian.
  • 9. Khoseva E.N., Morozova T.E. Problematic aspects of the development of the pharmacovigilance system in the Russian Federation at the present stage (review). Kachestvennaja klinicheskaja praktika. 2013;3:40-45. Russian.
  • 10. Burashnikova I.S. Comparative analysis of adverse reactions when using typical and atypical antipsychotics. Bulletin of Roszdravnadzor. 2016;5:61-65. Russian.
  • 11. Glagolev S.V., Polivanov V.A., Chizhova D.A., Gorelov K.V. Drug Safety Monitoring: Status and Prospects. Bulletin of Roszdravnadzor. 2013;4:17-20. Russian.
  • 12. Shehab N., Lovegrove M.C., Geller A.I., Rose K.O., Weidle N.J., Budnitz D.S. US emergency department visits for outpatient adverse drug events, 2013-2014. JAMA. 2016;316(20):2115-2125. DOI: 10.1001/jama.2016.16201
  • 13. Demchenkova E.Yu., Gorodetskaya G.I., Mazerkina I.A., Zhuravleva M.V., Kazakov A.S., Gorodetskiy M.V., et al. Current issues of detection and monitoring of adverse reactions when using cephalosporin antibiotics. Safety and risk of pharmacotherapy. 2021;9(1):34-42. Russian. DOI: 10.30895/23127821-2021-9-1-34-42
  • 14. Top 10 popular prescription drugs in Russia. GxP News. From 01.09.2022. Available at: https://gxpnews.net/2022/09/top-10-samyh-populyarnyh-reczepturnyhpreparatov-rossii/ Accessed March 29, 2023. Russian.
  • 15. Hansen M.P., Scott A.M., McCullough A., Thorning S., Aronson J.K., Beller E.M., et al. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Database Syst Rev. 2019;1(1):CD011825. DOI: 10.1002/14651858.CD011825.pub2
  • 16. Sinopal'nikov A.I., Andreeva I.V., Stetsyuk O.U. Safety of macrolide antibiotics: a critical review. Clinical medicine. 2012;90(3):23-30. Russian.
  • 17. Safin A.L., Achkasov S.I., Sukhina M.A., Sushkov O.I. Clostridium difficile infection: clinic, diagnosis and treatment (literature review). Coloproctology. 2017;2(60):80-88. Russian. DOI: 10.33878/2073-7556-2017-0-2-80-88
  • 18. Shay S.E., Yakovleva Yu.V. Effect of macrolide antibiotics on the QT interval. Young Scientist. 2021;27(369):102105. Russian.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared